FDA DEVICE FACTS
cobas HPV for use on the cobas 6800/8800 Systems
Roche Molecular Systems, Inc.
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
cobas HPV for use on the cobas 6800/88 00 Systems (cobas HPV) is a qualitative in vitro test for the detection of Human Papillo mavirus in clinician-collected cervical specimens using an endocervical brush/spat ula or broom and placed in the ThinPrep Pap Test PreservCyt Solution. This test de tects the high-risk HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 , 66, and 68.
cobas HPV is indicated for use for r outine cervical cancer screening as per professional medical guidelines, including triage of ASC-US cytology, co-testing (or adjunctive screen) with cytology, a nd HPV primary screening of women to assess the risk for cervical precancer and cancer. Patients should be followed-up in accordance with professional medical guide lines, results from prior screening, medical history, and other risk factors.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。